Op-eds: Canadian and American regulators, law enforcement and patient advocates oppose drug importation

Since 2000, every head of the United States Food and Drug Administration (FDA) and United States Department of Health and Human Services (HHS) has opposed drug importation because the benefits that might be gained are far outweighed by the many dangers. Law enforcement, patient advocates, pharmacy groups, and regulators agree.

Drug importation will “jeopardize the health and well-being of millions of Americans,” Pacific Research Institute CEO warns

Feb 7, 2019

In this editorial, which was published in The Des Moines Register on February 7, 2019, Pacific Research Institute CEO Sally Pipes explains why drug importation is not the right way to lower costs.

A Colorado Woman Was Seriously Ill. No One Suspected Her Imported Drugs.

Feb 5, 2019

In this February 4th, 2019 editorial for Colorado Politics, Denver resident Ali Schroer warns, “I experienced firsthand the dangers of counterfeit, imported drugs, and was critically ill for months as we sought to uncover the source of my illness.”

Importation is “extremely dangerous idea,” says former FBI Director Freeh

Jan 31, 2019

In this editorial, which first appeared in The Washington Times on January 29, 2019, former FBI Director Louis J. Freeh revisits the problem drug importation poses to law enforcement and regulatory systems already overburdened by the opioid crisis.

National Association of Manufacturers Exec warns, “Importation Proposals Disguise Serious Risks”

Jan 31, 2019

In this January 30, 2019 editorial, which was published in the National Association of Manufacturer’s Shopfloor blog, Vice President of Infrastructure Robyn Boerstling warns that even though legislators have good intentions, importation could “result in disastrous outcomes.”

Importation Is Too Risky, Warns Former FDA Associate Commissioner

Jan 23, 2019

In a January 23, 2019 editorial published in The Hill Peter Pitts, a former FDA associate commissioner and the president of the Center for Medicine in the Public Interest, explains why the safety risks of importation far outweigh any savings.

Side Stepping FDA Safeguards to Buy Medicine in Mexico Isn’t Safe, Former DEA Agents Warn

Dec 10, 2018

In this editorial, which was published in The Salt Lake Tribune on December 10, 2018, former DEA agents Javier Peña and Steve Murphy, warn that importing prescription drugs from other countries is “an extremely risky enterprise with potentially tragic consequences.”

Former Ontario Police Superintendent Warns That Gang-Backed Fentanyl Trafficking Threatens both Canada and the U.S.

Nov 20, 2018

In this editorial, which appeared in Inside Sources on November 20, 2018, former chief superintendent of the Ontario Provincial Police Don Bell discusses the threat that gang-backed fentanyl trafficking poses to the U.S. and Canada, and emphasizes the importance of working together to secure the border.

Pharmacist and Drug Safety Advocate Urge HHS to Consider the Dangers of Importation

Oct 17, 2018

In this October 16, 2018 for Drug Topics, Alliance of Safe Online Pharmacies advisor Libby Baney and pharmacist and American Pharmacists Association CEO Thomas Menighan discuss the risks to public safety posed by drug importation.

Chairman and Editor In Chief Warns That Allowing Drug Importation Is All Risk And No Reward

Oct 10, 2018

In this October 10, 2018 editorial for The Hill, publishing executive warns that America has nothing to gain and everything to lose if we forsake our secure drug supply chain for allowing the importation of dangerous drugs…

President Of Nonprofit Warns That Allowing Foreign Drug Importation Is A Threat To U.S. Patients

Sep 18, 2018

In this September 17, 2018, editorial for The Detroit News, the Center for Medicine in the Public Interest’s President and co-founder Peter Pitts warned that legalizing prescription drug importation will not generate massive savings for U.S. citizens while also potentially exposing millions of Americans to dangerous counterfeit drugs…